Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

The combination of encorafenib and binimetinib caused few skin issues.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Tofacitinib is a promising treatment for children with rheumatic diseases.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Cancer treatments can cause various eye problems, so eye doctors should know how to diagnose and treat these early.

Ritlecitinib is safe and may effectively treat alopecia areata.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Cepharanthine shows promise as a COVID-19 treatment.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Combining CAF regimen with fufangbanmao capsules improves thyroid cancer treatment outcomes and reduces side effects.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Deucravacitinib helped a man regrow hair significantly.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Letrozole may help prevent seizures by reducing certain hormone levels.